RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipharm Labs Stock

Medipharm Labs ROA 2024

Medipharm Labs ROA

-0.2

Ticker

LABS.TO

ISIN

CA58504D1006

WKN

A2N7AA

In 2024, Medipharm Labs's return on assets (ROA) was -0.2, a -55.32% increase from the -0.46 ROA in the previous year.

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Medipharm Labs's Return on Assets (ROA)

Medipharm Labs's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Medipharm Labs's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Medipharm Labs's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Medipharm Labs’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Medipharm Labs stock

What is the Return on Assets (ROA) of Medipharm Labs this year?

The Return on Assets (ROA) of Medipharm Labs is -0.2 undefined this year.

What was the ROA of Medipharm Labs compared to the previous year?

The ROA of Medipharm Labs has increased by -55.32% compared to the previous year.

What consequences do high ROA have for investors of Medipharm Labs?

A high ROA is advantageous for investors of Medipharm Labs, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Medipharm Labs?

A low ROA can be unfavorable for investors of Medipharm Labs as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Medipharm Labs affect the company?

An increase in ROA of Medipharm Labs can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Medipharm Labs impact the company?

A reduction in the ROA of Medipharm Labs can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Medipharm Labs?

Some factors that can influence the ROA of Medipharm Labs include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Medipharm Labs important for investors?

The ROA of Medipharm Labs is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Medipharm Labs take to improve ROA?

To improve ROA, Medipharm Labs can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 10/4/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 10/4/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipharm Labs

Our stock analysis for Medipharm Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipharm Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.